NCT06098547
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Azienda Ospedale Università di Padova Padova, Italy
Clinical trial condition
Intrahepatic Cholangiocarcinoma
Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
72 public trials
33 recruiting studies
Intrahepatic Cholangiocarcinoma trial results
NCT04556214
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Oslo University Hospital Oslo, Norway
NCT04078230
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- The Johns Hopkins Hospital Baltimore, Maryland, United States
- China-Japan Friendship Hospital Beijing, Beijing Municipality, China
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
Not Yet Recruiting
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
NCT07715903
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +26 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Not Yet Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma
NCT07522476
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- The First Affiliated Hospital，Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Not Yet Recruiting
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC
NCT07432568
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
NCT06567600
- Conditions
- Adenocarcinoma, Carcinoma, Chemotherapy Effect, +6 more
- Locations
-
- The Third Affiliated Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
Not Yet Recruiting
A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
NCT06375642
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma
NCT06313554
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
Not specified
Not Yet Recruiting
The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases
NCT05896956
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +22 more
- Locations
-
Not specified